866-997-4948(US-Canada Toll Free)

Europe Active Pharmaceutical Ingredients Market Report 2017

Published By :

QYResearch

Published Date : Feb 2017

Category :

Pharmaceutical

No. of Pages : 126 Pages

Notes:
Sales, means the sales volume of Active Pharmaceutical Ingredients
Revenue, means the sales value of Active Pharmaceutical Ingredients

This report studies sales (consumption) of Active Pharmaceutical Ingredients in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering
Pfizer
Novartis International
Sanofi
Boehringer Ingelheim
Bristol-Myers Squibb
Teva Pharmaceutical
Eli Lilly and Company
GlaxoSmithKline
Merck & Co
AbbVie
Johnson & Johnson
Bayer
Sun Pharmaceutical Industries
DSM
Hisun Pharmacy
Huahai Pharmaceutical
North China Pharmaceutical Group
Shandong Lukang Pharmaceutical
Haerbin Pharmaceutical Group
Shandong Xinhua Pharmaceutical
Jiangsu Hengrui Medicine
Lonza Group
Aurobindo Pharma
Lupin
Biocon

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Active Pharmaceutical Ingredients in these countries, from 2011 to 2021 (forecast), like
Germany
France
UK
Russia
Italy
Spain
Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into
Synthetic APIs
Biotech APIs

Split by application, this report focuses on sales, market share and growth rate of Active Pharmaceutical Ingredients in each application, can be divided into
Oncology
Diabetes
Cardiovascular Disease
CNS and Neurological Disorders
Endocrinology
Other

Table of Contents

Europe Active Pharmaceutical Ingredients Market Report 2017
1 Active Pharmaceutical Ingredients Overview
1.1 Product Overview and Scope of Active Pharmaceutical Ingredients
1.2 Classification of Active Pharmaceutical Ingredients
1.2.1 Synthetic APIs
1.2.2 Biotech APIs
1.3 Application of Active Pharmaceutical Ingredients
1.3.1 Oncology
1.3.2 Diabetes
1.3.3 Cardiovascular Disease
1.3.4 CNS and Neurological Disorders
1.3.5 Endocrinology
1.3.6 Other
1.4 Active Pharmaceutical Ingredients Market by Countries
1.4.1 Germany Status and Prospect (2012-2022)
1.4.2 France Status and Prospect (2012-2022)
1.4.3 UK Status and Prospect (2012-2022)
1.4.4 Russia Status and Prospect (2012-2022)
1.4.5 Italy Status and Prospect (2012-2022)
1.4.6 Spain Status and Prospect (2012-2022)
1.4.7 Benelux Status and Prospect (2012-2022)
1.5 Europe Market Size (Value and Volume) of Active Pharmaceutical Ingredients (2012-2022)
1.5.1 Europe Active Pharmaceutical Ingredients Sales and Growth Rate (2012-2022)
1.5.2 Europe Active Pharmaceutical Ingredients Revenue and Growth Rate (2012-2022)

2 Europe Active Pharmaceutical Ingredients by Manufacturers, Type and Application
2.1 Europe Active Pharmaceutical Ingredients Market Competition by Manufacturers
2.1.1 Europe Active Pharmaceutical Ingredients Sales and Market Share of Key Manufacturers (2015 and 2016)
2.1.2 Europe Active Pharmaceutical Ingredients Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Active Pharmaceutical Ingredients (Volume and Value) by Type
2.2.1 Europe Active Pharmaceutical Ingredients Sales and Market Share by Type (2012-2017)
2.2.2 Europe Active Pharmaceutical Ingredients Revenue and Market Share by Type (2012-2017)
2.3 Europe Active Pharmaceutical Ingredients (Volume and Value) by Countries
2.3.1 Europe Active Pharmaceutical Ingredients Sales and Market Share by Countries (2012-2017)
2.3.2 Europe Active Pharmaceutical Ingredients Revenue and Market Share by Countries (2012-2017)
2.4 Europe Active Pharmaceutical Ingredients (Volume) by Application

3 Germany Active Pharmaceutical Ingredients (Volume, Value and Sales Price)
3.1 Germany Active Pharmaceutical Ingredients Sales and Value (2012-2017)
3.1.1 Germany Active Pharmaceutical Ingredients Sales and Growth Rate (2012-2017)
3.1.2 Germany Active Pharmaceutical Ingredients Revenue and Growth Rate (2012-2017)
3.1.3 Germany Active Pharmaceutical Ingredients Sales Price Trend (2012-2017)
3.2 Germany Active Pharmaceutical Ingredients Sales and Market Share by Manufacturers
3.3 Germany Active Pharmaceutical Ingredients Sales and Market Share by Type
3.4 Germany Active Pharmaceutical Ingredients Sales and Market Share by Application

4 France Active Pharmaceutical Ingredients (Volume, Value and Sales Price)
4.1 France Active Pharmaceutical Ingredients Sales and Value (2012-2017)
4.1.1 France Active Pharmaceutical Ingredients Sales and Growth Rate (2012-2017)
4.1.2 France Active Pharmaceutical Ingredients Revenue and Growth Rate (2012-2017)
4.1.4 France Active Pharmaceutical Ingredients Sales Price Trend (2012-2017)
4.2 France Active Pharmaceutical Ingredients Sales and Market Share by Manufacturers
4.3 France Active Pharmaceutical Ingredients Sales and Market Share by Type
4.4 France Active Pharmaceutical Ingredients Sales and Market Share by Application

5 UK Active Pharmaceutical Ingredients (Volume, Value and Sales Price)
5.1 UK Active Pharmaceutical Ingredients Sales and Value (2012-2017)
5.1.1 UK Active Pharmaceutical Ingredients Sales and Growth Rate (2012-2017)
5.1.2 UK Active Pharmaceutical Ingredients Revenue and Growth Rate (2012-2017)
5.1.5 UK Active Pharmaceutical Ingredients Sales Price Trend (2012-2017)
5.2 UK Active Pharmaceutical Ingredients Sales and Market Share by Manufacturers
5.3 UK Active Pharmaceutical Ingredients Sales and Market Share by Type
5.4 UK Active Pharmaceutical Ingredients Sales and Market Share by Application

6 Russia Active Pharmaceutical Ingredients (Volume, Value and Sales Price)
6.1 Russia Active Pharmaceutical Ingredients Sales and Value (2012-2017)
6.1.1 Russia Active Pharmaceutical Ingredients Sales and Growth Rate (2012-2017)
6.1.2 Russia Active Pharmaceutical Ingredients Revenue and Growth Rate (2012-2017)
6.1.6 Russia Active Pharmaceutical Ingredients Sales Price Trend (2012-2017)
6.2 Russia Active Pharmaceutical Ingredients Sales and Market Share by Manufacturers
6.3 Russia Active Pharmaceutical Ingredients Sales and Market Share by Type
6.4 Russia Active Pharmaceutical Ingredients Sales and Market Share by Application

7 Italy Active Pharmaceutical Ingredients (Volume, Value and Sales Price)
7.1 Italy Active Pharmaceutical Ingredients Sales and Value (2012-2017)
7.1.1 Italy Active Pharmaceutical Ingredients Sales and Growth Rate (2012-2017)
7.1.2 Italy Active Pharmaceutical Ingredients Revenue and Growth Rate (2012-2017)
7.1.7 Italy Active Pharmaceutical Ingredients Sales Price Trend (2012-2017)
7.2 Italy Active Pharmaceutical Ingredients Sales and Market Share by Manufacturers
7.3 Italy Active Pharmaceutical Ingredients Sales and Market Share by Type
7.4 Italy Active Pharmaceutical Ingredients Sales and Market Share by Application

8 Spain Active Pharmaceutical Ingredients (Volume, Value and Sales Price)
8.1 Spain Active Pharmaceutical Ingredients Sales and Value (2012-2017)
8.1.1 Spain Active Pharmaceutical Ingredients Sales and Growth Rate (2012-2017)
8.1.2 Spain Active Pharmaceutical Ingredients Revenue and Growth Rate (2012-2017)
8.1.8 Spain Active Pharmaceutical Ingredients Sales Price Trend (2012-2017)
8.2 Spain Active Pharmaceutical Ingredients Sales and Market Share by Manufacturers
8.3 Spain Active Pharmaceutical Ingredients Sales and Market Share by Type
8.4 Spain Active Pharmaceutical Ingredients Sales and Market Share by Application

9 Benelux Active Pharmaceutical Ingredients (Volume, Value and Sales Price)
9.1 Benelux Active Pharmaceutical Ingredients Sales and Value (2012-2017)
9.1.1 Benelux Active Pharmaceutical Ingredients Sales and Growth Rate (2012-2017)
9.1.2 Benelux Active Pharmaceutical Ingredients Revenue and Growth Rate (2012-2017)
9.1.9 Benelux Active Pharmaceutical Ingredients Sales Price Trend (2012-2017)
9.2 Benelux Active Pharmaceutical Ingredients Sales and Market Share by Manufacturers
9.3 Benelux Active Pharmaceutical Ingredients Sales and Market Share by Type
9.4 Benelux Active Pharmaceutical Ingredients Sales and Market Share by Application

10 Europe Active Pharmaceutical Ingredients Manufacturers Analysis
10.1 Pfizer
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 Active Pharmaceutical Ingredients Product Type, Application and Specification
10.1.2.1 Synthetic APIs
10.1.2.2 Biotech APIs
10.1.3 Pfizer Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2012-2017)
10.1.4 Main Business/Business Overview
10.2 Novartis International
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 Active Pharmaceutical Ingredients Product Type, Application and Specification
10.2.2.1 Synthetic APIs
10.2.2.2 Biotech APIs
10.2.3 Novartis International Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2012-2017)
10.2.4 Main Business/Business Overview
10.3 Sanofi
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 Active Pharmaceutical Ingredients Product Type, Application and Specification
10.3.2.1 Synthetic APIs
10.3.2.2 Biotech APIs
10.3.3 Sanofi Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2012-2017)
10.3.4 Main Business/Business Overview
10.4 Boehringer Ingelheim
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 Active Pharmaceutical Ingredients Product Type, Application and Specification
10.4.2.1 Synthetic APIs
10.4.2.2 Biotech APIs
10.4.3 Boehringer Ingelheim Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2012-2017)
10.4.4 Main Business/Business Overview
10.5 Bristol-Myers Squibb
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 Active Pharmaceutical Ingredients Product Type, Application and Specification
10.5.2.1 Synthetic APIs
10.5.2.2 Biotech APIs
10.5.3 Bristol-Myers Squibb Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2012-2017)
10.5.4 Main Business/Business Overview
10.6 Teva Pharmaceutical
10.6.1 Company Basic Information, Manufacturing Base and Competitors
10.6.2 Active Pharmaceutical Ingredients Product Type, Application and Specification
10.6.2.1 Synthetic APIs
10.6.2.2 Biotech APIs
10.6.3 Teva Pharmaceutical Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2012-2017)
10.6.4 Main Business/Business Overview
10.7 Eli Lilly and Company
10.7.1 Company Basic Information, Manufacturing Base and Competitors
10.7.2 Active Pharmaceutical Ingredients Product Type, Application and Specification
10.7.2.1 Synthetic APIs
10.7.2.2 Biotech APIs
10.7.3 Eli Lilly and Company Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2012-2017)
10.7.4 Main Business/Business Overview
10.8 GlaxoSmithKline
10.8.1 Company Basic Information, Manufacturing Base and Competitors
10.8.2 Active Pharmaceutical Ingredients Product Type, Application and Specification
10.8.2.1 Synthetic APIs
10.8.2.2 Biotech APIs
10.8.3 GlaxoSmithKline Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2012-2017)
10.8.4 Main Business/Business Overview
10.9 Merck & Co
10.9.1 Company Basic Information, Manufacturing Base and Competitors
10.9.2 Active Pharmaceutical Ingredients Product Type, Application and Specification
10.9.2.1 Synthetic APIs
10.9.2.2 Biotech APIs
10.9.3 Merck & Co Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2012-2017)
10.9.4 Main Business/Business Overview
10.10 AbbVie
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Active Pharmaceutical Ingredients Product Type, Application and Specification
10.10.2.1 Synthetic APIs
10.10.2.2 Biotech APIs
10.10.3 AbbVie Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2012-2017)
10.10.4 Main Business/Business Overview
10.11 Johnson & Johnson
10.12 Bayer
10.13 Sun Pharmaceutical Industries
10.14 DSM
10.15 Hisun Pharmacy
10.16 Huahai Pharmaceutical
10.17 North China Pharmaceutical Group
10.18 Shandong Lukang Pharmaceutical
10.19 Haerbin Pharmaceutical Group
10.20 Shandong Xinhua Pharmaceutical
10.21 Jiangsu Hengrui Medicine
10.22 Lonza Group
10.23 Aurobindo Pharma
10.24 Lupin
10.25 Biocon

11 Active Pharmaceutical Ingredients Manufacturing Cost Analysis
11.1 Active Pharmaceutical Ingredients Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Active Pharmaceutical Ingredients

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Active Pharmaceutical Ingredients Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Active Pharmaceutical Ingredients Major Manufacturers in 2015
12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List

14 Europe Active Pharmaceutical Ingredients Market Forecast (2017-2022)
14.1 Germany Active Pharmaceutical Ingredients Sales Forecast (2017-2022)
14.2 France Active Pharmaceutical Ingredients Sales Forecast (2017-2022)
14.3 UK Active Pharmaceutical Ingredients Sales Forecast (2017-2022)
14.4 Russia Active Pharmaceutical Ingredients Sales Forecast (2017-2022)
14.5 Italy Active Pharmaceutical Ingredients Sales Forecast (2017-2022)
14.6 Spain Active Pharmaceutical Ingredients Sales Forecast (2017-2022)
14.7 Benelux Active Pharmaceutical Ingredients Sales Forecast (2017-2022)
14.8 Europe Active Pharmaceutical Ingredients Sales Forecast by Type (2017-2022)
14.9 Europe Active Pharmaceutical Ingredients Sales Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
Methodology
Analyst Introduction
Data Source


List of Table

List of Tables and Figures

Figure Picture of Active Pharmaceutical Ingredients
Table Classification of Active Pharmaceutical Ingredients
Figure Europe Sales Market Share of Active Pharmaceutical Ingredients by Type in 2015
Figure Synthetic APIs Picture
Figure Biotech APIs Picture
Table Application of Active Pharmaceutical Ingredients
Figure Europe Sales Market Share of Active Pharmaceutical Ingredients by Application in 2015
Figure Oncology Examples
Figure Diabetes Examples
Figure Cardiovascular Disease Examples
Figure CNS and Neurological Disorders Examples
Figure Endocrinology Examples
Figure Other Examples
Figure Germany Active Pharmaceutical Ingredients Revenue and Growth Rate (2012-2022)
Figure France Active Pharmaceutical Ingredients Revenue and Growth Rate (2012-2022)
Figure UK Active Pharmaceutical Ingredients Revenue and Growth Rate (2012-2022)
Figure Russia Active Pharmaceutical Ingredients Revenue and Growth Rate (2012-2022)
Figure Italy Active Pharmaceutical Ingredients Revenue and Growth Rate (2012-2022)
Figure Spain Active Pharmaceutical Ingredients Revenue and Growth Rate (2012-2022)
Figure Benelux Active Pharmaceutical Ingredients Revenue and Growth Rate (2012-2022)
Figure Europe Active Pharmaceutical Ingredients Sales and Growth Rate (2012-2022)
Figure Europe Active Pharmaceutical Ingredients Revenue and Growth Rate (2012-2022)
Table Europe Active Pharmaceutical Ingredients Sales of Key Manufacturers (2015 and 2016)
Table Europe Active Pharmaceutical Ingredients Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Active Pharmaceutical Ingredients Sales Share by Manufacturers
Figure 2016 Active Pharmaceutical Ingredients Sales Share by Manufacturers
Table Europe Active Pharmaceutical Ingredients Revenue by Manufacturers (2015 and 2016)
Table Europe Active Pharmaceutical Ingredients Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Active Pharmaceutical Ingredients Revenue Share by Manufacturers
Table 2016 Europe Active Pharmaceutical Ingredients Revenue Share by Manufacturers
Table Europe Active Pharmaceutical Ingredients Sales and Market Share by Type (2012-2017)
Table Europe Active Pharmaceutical Ingredients Sales Share by Type (2012-2017)
Figure Sales Market Share of Active Pharmaceutical Ingredients by Type (2012-2017)
Figure Europe Active Pharmaceutical Ingredients Sales Growth Rate by Type (2012-2017)
Table Europe Active Pharmaceutical Ingredients Revenue and Market Share by Type (2012-2017)
Table Europe Active Pharmaceutical Ingredients Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Active Pharmaceutical Ingredients by Type (2012-2017)
Figure Europe Active Pharmaceutical Ingredients Revenue Growth Rate by Type (2012-2017)
Table Europe Active Pharmaceutical Ingredients Sales and Market Share by Countries (2012-2017)
Table Europe Active Pharmaceutical Ingredients Sales Share by Countries (2012-2017)
Figure Sales Market Share of Active Pharmaceutical Ingredients by Countries (2012-2017)
Table Europe Active Pharmaceutical Ingredients Revenue and Market Share by Countries (2012-2017)
Table Europe Active Pharmaceutical Ingredients Revenue Share by Countries (2012-2017)
Figure Revenue Market Share of Active Pharmaceutical Ingredients by Countries (2012-2017)
Table Europe Active Pharmaceutical Ingredients Sales and Market Share by Application (2012-2017)
Table Europe Active Pharmaceutical Ingredients Sales Share by Application (2012-2017)
Figure Sales Market Share of Active Pharmaceutical Ingredients by Application (2012-2017)
Figure Germany Active Pharmaceutical Ingredients Sales and Growth Rate (2012-2017)
Figure Germany Active Pharmaceutical Ingredients Revenue and Growth Rate (2012-2017)
Figure Germany Active Pharmaceutical Ingredients Sales Price Trend (2012-2017)
Table Germany Active Pharmaceutical Ingredients Sales by Manufacturers (2015 and 2016)
Table Germany Active Pharmaceutical Ingredients Market Share by Manufacturers (2015 and 2016)
Table Germany Active Pharmaceutical Ingredients Sales by Type (2015 and 2016)
Table Germany Active Pharmaceutical Ingredients Market Share by Type (2015 and 2016)
Table Germany Active Pharmaceutical Ingredients Sales by Application (2015 and 2016)
Table Germany Active Pharmaceutical Ingredients Market Share by Application (2015 and 2016)
Figure France Active Pharmaceutical Ingredients Sales and Growth Rate (2012-2017)
Figure France Active Pharmaceutical Ingredients Revenue and Growth Rate (2012-2017)
Figure France Active Pharmaceutical Ingredients Sales Price Trend (2012-2017)
Table France Active Pharmaceutical Ingredients Sales by Manufacturers (2015 and 2016)
Table France Active Pharmaceutical Ingredients Market Share by Manufacturers (2015 and 2016)
Table France Active Pharmaceutical Ingredients Sales by Type (2015 and 2016)
Table France Active Pharmaceutical Ingredients Market Share by Type (2015 and 2016)
Table France Active Pharmaceutical Ingredients Sales by Application (2015 and 2016)
Table France Active Pharmaceutical Ingredients Market Share by Application (2015 and 2016)
Figure UK Active Pharmaceutical Ingredients Sales and Growth Rate (2012-2017)
Figure UK Active Pharmaceutical Ingredients Revenue and Growth Rate (2012-2017)
Figure UK Active Pharmaceutical Ingredients Sales Price Trend (2012-2017)
Table UK Active Pharmaceutical Ingredients Sales by Manufacturers (2015 and 2016)
Table UK Active Pharmaceutical Ingredients Market Share by Manufacturers (2015 and 2016)
Table UK Active Pharmaceutical Ingredients Sales by Type (2015 and 2016)
Table UK Active Pharmaceutical Ingredients Market Share by Type (2015 and 2016)
Table UK Active Pharmaceutical Ingredients Sales by Application (2015 and 2016)
Table UK Active Pharmaceutical Ingredients Market Share by Application (2015 and 2016)
Figure Russia Active Pharmaceutical Ingredients Sales and Growth Rate (2012-2017)
Figure Russia Active Pharmaceutical Ingredients Revenue and Growth Rate (2012-2017)
Figure Russia Active Pharmaceutical Ingredients Sales Price Trend (2012-2017)
Table Russia Active Pharmaceutical Ingredients Sales by Manufacturers (2015 and 2016)
Table Russia Active Pharmaceutical Ingredients Market Share by Manufacturers (2015 and 2016)
Table Russia Active Pharmaceutical Ingredients Sales by Type (2015 and 2016)
Table Russia Active Pharmaceutical Ingredients Market Share by Type (2015 and 2016)
Table Russia Active Pharmaceutical Ingredients Sales by Application (2015 and 2016)
Table Russia Active Pharmaceutical Ingredients Market Share by Application (2015 and 2016)
Figure Italy Active Pharmaceutical Ingredients Sales and Growth Rate (2012-2017)
Figure Italy Active Pharmaceutical Ingredients Revenue and Growth Rate (2012-2017)
Figure Italy Active Pharmaceutical Ingredients Sales Price Trend (2012-2017)
Table Italy Active Pharmaceutical Ingredients Sales by Manufacturers (2015 and 2016)
Table Italy Active Pharmaceutical Ingredients Market Share by Manufacturers (2015 and 2016)
Table Italy Active Pharmaceutical Ingredients Sales by Type (2015 and 2016)
Table Italy Active Pharmaceutical Ingredients Market Share by Type (2015 and 2016)
Table Italy Active Pharmaceutical Ingredients Sales by Application (2015 and 2016)
Table Italy Active Pharmaceutical Ingredients Market Share by Application (2015 and 2016)
Figure Spain Active Pharmaceutical Ingredients Sales and Growth Rate (2012-2017)
Figure Spain Active Pharmaceutical Ingredients Revenue and Growth Rate (2012-2017)
Figure Spain Active Pharmaceutical Ingredients Sales Price Trend (2012-2017)
Table Spain Active Pharmaceutical Ingredients Sales by Manufacturers (2015 and 2016)
Table Spain Active Pharmaceutical Ingredients Market Share by Manufacturers (2015 and 2016)
Table Spain Active Pharmaceutical Ingredients Sales by Type (2015 and 2016)
Table Spain Active Pharmaceutical Ingredients Market Share by Type (2015 and 2016)
Table Spain Active Pharmaceutical Ingredients Sales by Application (2015 and 2016)
Table Spain Active Pharmaceutical Ingredients Market Share by Application (2015 and 2016)
Figure Benelux Active Pharmaceutical Ingredients Sales and Growth Rate (2012-2017)
Figure Benelux Active Pharmaceutical Ingredients Revenue and Growth Rate (2012-2017)
Figure Benelux Active Pharmaceutical Ingredients Sales Price Trend (2012-2017)
Table Benelux Active Pharmaceutical Ingredients Sales by Manufacturers (2015 and 2016)
Table Benelux Active Pharmaceutical Ingredients Market Share by Manufacturers (2015 and 2016)
Table Benelux Active Pharmaceutical Ingredients Sales by Type (2015 and 2016)
Table Benelux Active Pharmaceutical Ingredients Market Share by Type (2015 and 2016)
Table Benelux Active Pharmaceutical Ingredients Sales by Application (2015 and 2016)
Table Benelux Active Pharmaceutical Ingredients Market Share by Application (2015 and 2016)
Table Active Pharmaceutical Ingredients Basic Information List
Table Pfizer Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Active Pharmaceutical Ingredients Sales Market Share (2012-2017)
Table Novartis International Basic Information List
Table Novartis International Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2012-2017)
Table Novartis International Active Pharmaceutical Ingredients Sales Market Share (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2012-2017)
Table Sanofi Active Pharmaceutical Ingredients Sales Market Share (2012-2017)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2012-2017)
Table Boehringer Ingelheim Active Pharmaceutical Ingredients Sales Market Share (2012-2017)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2012-2017)
Table Bristol-Myers Squibb Active Pharmaceutical Ingredients Sales Market Share (2012-2017)
Table Teva Pharmaceutical Basic Information List
Table Teva Pharmaceutical Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2012-2017)
Table Teva Pharmaceutical Active Pharmaceutical Ingredients Sales Market Share (2012-2017)
Table Eli Lilly and Company Basic Information List
Table Eli Lilly and Company Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2012-2017)
Table Eli Lilly and Company Active Pharmaceutical Ingredients Sales Market Share (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2012-2017)
Table GlaxoSmithKline Active Pharmaceutical Ingredients Sales Market Share (2012-2017)
Table Merck & Co Basic Information List
Table Merck & Co Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2012-2017)
Table Merck & Co Active Pharmaceutical Ingredients Sales Market Share (2012-2017)
Table AbbVie Basic Information List
Table AbbVie Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2012-2017)
Table AbbVie Active Pharmaceutical Ingredients Sales Market Share (2012-2017)
Table Johnson & Johnson Basic Information List
Table Bayer Basic Information List
Table Sun Pharmaceutical Industries Basic Information List
Table DSM Basic Information List
Table Hisun Pharmacy Basic Information List
Table Huahai Pharmaceutical Basic Information List
Table North China Pharmaceutical Group Basic Information List
Table Shandong Lukang Pharmaceutical Basic Information List
Table Haerbin Pharmaceutical Group Basic Information List
Table Shandong Xinhua Pharmaceutical Basic Information List
Table Jiangsu Hengrui Medicine Basic Information List
Table Lonza Group Basic Information List
Table Aurobindo Pharma Basic Information List
Table Lupin Basic Information List
Table Biocon Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Active Pharmaceutical Ingredients
Figure Manufacturing Process Analysis of Active Pharmaceutical Ingredients
Figure Active Pharmaceutical Ingredients Industrial Chain Analysis
Table Raw Materials Sources of Active Pharmaceutical Ingredients Major Manufacturers in 2015
Table Major Buyers of Active Pharmaceutical Ingredients
Table Distributors/Traders List
Figure Germany Active Pharmaceutical Ingredients Sales and Growth Rate Forecast (2017-2022)
Figure Germany Active Pharmaceutical Ingredients Revenue and Growth Rate Forecast (2017-2022)
Figure France Active Pharmaceutical Ingredients Sales and Growth Rate Forecast (2017-2022)
Figure France Active Pharmaceutical Ingredients Revenue and Growth Rate Forecast (2017-2022)
Figure UK Active Pharmaceutical Ingredients Sales and Growth Rate Forecast (2017-2022)
Figure UK Active Pharmaceutical Ingredients Revenue and Growth Rate Forecast (2017-2022)
Figure Russia Active Pharmaceutical Ingredients Sales and Growth Rate Forecast (2017-2022)
Figure Russia Active Pharmaceutical Ingredients Revenue and Growth Rate Forecast (2017-2022)
Figure Italy Active Pharmaceutical Ingredients Sales and Growth Rate Forecast (2017-2022)
Figure Italy Active Pharmaceutical Ingredients Revenue and Growth Rate Forecast (2017-2022)
Figure Spain Active Pharmaceutical Ingredients Sales and Growth Rate Forecast (2017-2022)
Figure Spain Active Pharmaceutical Ingredients Revenue and Growth Rate Forecast (2017-2022)
Figure Benelux Active Pharmaceutical Ingredients Sales and Growth Rate Forecast (2017-2022)
Figure Benelux Active Pharmaceutical Ingredients Revenue and Growth Rate Forecast (2017-2022)
Table Europe Active Pharmaceutical Ingredients Sales Forecast by Type (2017-2022)
Table Europe Active Pharmaceutical Ingredients Sales Forecast by Application (2017-2022)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *